SCHEMBL27422701

SCHEMBL27422701

CC(C)CC(C(=O)O)C1CCCCC1

nearest known ligand 0.53

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CPA1 P15085 1/20 0.53
CYP2C9 P11712 1/20 0.47
CYP2C19 P33261 1/20 0.47
HIF1A Q16665 1/20 0.47
EPHX1 P07099 2/20 0.44
MMP1 P03956 2/20 0.42
MMP9 P14780 2/20 0.42
MMP14 P50281 2/20 0.42
MMP2 P08253 3/20 0.41
MMP3 P08254 1/20 0.41
CA12 O43570 2/20 0.41
CA1 P00915 2/20 0.41
CA2 P00918 2/20 0.41
CA9 Q16790 2/20 0.41
ALDH1A1 P00352 3/20 0.40
MEN1 O00255 1/20 0.40
LMNA P02545 1/20 0.40
KMT2A Q03164 1/20 0.40
SMN1; SMN2 Q16637 1/20 0.40
CPN1 P15169 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Phosphine SCHEMBL27430185 0.98 CPA1 (0.52) CPA1CYP2C9CYP2C19HIF1AEPHX1
SCHEMBL27529776 0.83 CYP2C9 (0.44) CPA1CYP2C9CYP2C19HIF1AEPHX1
SCHEMBL28064653 0.81 SMN1; SMN2 (0.46) CYP2C9CYP2C19EPHX1MMP1MMP9
SCHEMBL11598265 0.79 CYP2C9 (0.44) CYP2C9CYP2C19HIF1AEPHX1ALDH1A1
SCHEMBL13711836 0.79 CYP2C9 (0.50) CYP2C9CYP2C19HIF1AEPHX1ALDH1A1
SCHEMBL9133567 0.79 CYP2C9 (0.50) CYP2C9CYP2C19HIF1AEPHX1ALDH1A1
Cyclohexane SCHEMBL253223 0.79 CYP2C9 (0.50) CYP2C9CYP2C19HIF1AEPHX1ALDH1A1
SCHEMBL506450 0.79 CYP2C9 (0.50) CYP2C9CYP2C19HIF1AEPHX1ALDH1A1
Cyclohexane SCHEMBL16341926 0.79 CYP2C9 (0.50) CYP2C9CYP2C19HIF1AEPHX1ALDH1A1
SCHEMBL12804034 0.79 CYP2C9 (0.50) CYP2C9CYP2C19HIF1AEPHX1ALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-102245564-A Crystalline forms of a 3-carboxypropyl-aminotetralin compound THERAVANCE INC 2011-11-16 CN disclosed
CN-101896455-A 3-Carboxypropyl-aminotetralin derivatives as mu opioid receptor antagonists THERAVANCE INC 2010-11-24 CN disclosed
CN-1044249-C Matrix metalloprotease inhibitors SYNTEX INC (US) 1999-07-21 CN disclosed
CN-1134153-A Matrix metalloprotease inhibitors SYNTEX INC (US) 1996-10-23 CN disclosed